The Centers for Disease Control and Prevention (CDC) will no longer recommend routine COVID-19 shots for healthy children and ...

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...

Healthy younger adults and children will no longer be automatically approved for annual COVID-19 vaccines under a new policy ...

The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...

The FDA is implementing stricter guidance for the approval of COVID-19 vaccines, according to a paper published in The New England Journal of Medicine.

In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid ...

The Trump administration announced Tuesday that going forward, COVID-19 vaccines would be FDA-approved only for people over ...

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

The FDA also requested Novavax conduct a phase 4 study in patients aged 50 to 64 years without high-risk conditions for severe COVID-19.

The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.

The agency recommends manufacturers update their vaccines to target the JN.1 strain. At the same time, HHS head Robert F.